ScholarIQanswers from OpenAlex & ORCID
Katherine L. Nathanson
ResearcherPublications, citations & collaboration network
Katherine L. Nathanson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Katherine L. Nathanson have?
ScholarIQindexed works
Katherine L. Nathanson has 1,127 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Katherine L. Nathanson have?
ScholarIQcitation count
Katherine L. Nathanson has 50,406 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Katherine L. Nathanson?
ScholarIQh-index
Katherine L. Nathanson has an h-index of 114 in OpenAlex.
What is the i10-index of Katherine L. Nathanson?
ScholarIQi10-index
Katherine L. Nathanson has an i10-index of 370 in OpenAlex.
What is the ORCID of Katherine L. Nathanson?
ScholarIQorcid
The ORCID for Katherine L. Nathanson is on the source record.
What is the OpenAlex record for Katherine L. Nathanson?
ScholarIQopenalex
The OpenAlex for Katherine L. Nathanson is on the source record.
What are the most-cited papers on Katherine L. Nathanson?
ScholarIQmost cited works
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu, Steven N. Hart, Rohan Gnanaolivu, Hongyan Huang, Kun Y. Lee, Jie Na, Chi Gao, Jenna Lilyquist, Siddhartha Yadav, Nicholas Boddicker, Raed Samara, Josh Klebba, Christine B. Ambrosone, Hoda Anton‐Culver, Paul L. Auer, Elisa V. Bandera, Leslie Bernstein, Kimberly A. Bertrand, Elizabeth S. Burnside, Brian D. Carter, Heather Eliassen, Susan M. Gapstur, Mia M. Gaudet, Christopher A. Haiman, James M. Hodge, David J. Hunter, Eric J. Jacobs, Esther M. John, Charles Kooperberg, Allison W. Kurian, Loı̈c Le Marchand, Sara Lindströem, Tricia Lindstrom, Huiyan Ma, Susan L. Neuhausen, Polly A. Newcomb, Katie M. O’Brien, Janet E. Olson, Irene M. Ong, Tuya Pal, Julie R. Palmer, Alpa V. Patel, Sonya Reid, Lynn Rosenberg, Dale P. Sandler, Christopher J. Scott, Rulla M. Tamimi, Jack A. Taylor, Amy Trentham‐Dietz, Celine M. Vachon, Clarice R. Weinberg, Song Yao, Argyrios Ziogas, Jeffrey N. Weitzel, David E. Goldgar, Susan M. Domchek, Katherine L. Nathanson, Peter Kraft, Eric C. Polley, Fergus J. Couch
Network modeling links breast cancer susceptibility and centrosome dysfunction
Miguel Ángel Pujana, Jing-Dong Han, Lea M. Starita, Kristen N. Stevens, Muneesh Tewari, Jin Sook Ahn, Gad Rennert, Vı́ctor Moreno, Tomas Kirchhoff, Bert Gold, Volker Assmann, Wael M. ElShamy, Jean‐François Rual, Douglas A. Levine, Laura S. Rozek, Rebecca Gelman, Kristin C. Gunsalus, Roger A. Greenberg, Bijan Sobhian, Nicolas Bertin, K. Venkatesan, Nono Ayivi-Guedehoussou, Xavier Solé, Pilar Hernández, Conxi Lázaro, Katherine L. Nathanson, Barbara L. Weber, Michael E. Cusick, David E. Hill, Kenneth Offit, David M. Livingston, Stephen B. Gruber, Jeffrey D. Parvin, Marc Vidal
PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
Kim H.T. Paraiso, Yun Xiang, Vito W. Rebecca, Ethan V. Abel, Y. Ann Chen, A. Cecilia Munko, Elizabeth R. Wood, Inna V. Fedorenko, Vernon K. Sondak, Alexander R.A. Anderson, Antoni Ribas, Maurizia Dalla Palma, Katherine L. Nathanson, John M. Koomen, Jane L. Messina, Keiran S.M. Smalley
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
Timothy R. Rebbeck, Nandita Mitra, Fei Wan, Olga M. Sinilnikova, Sue Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix‐Trench, Douglas F. Easton, Antonis C. Antoniou, Katherine L. Nathanson, Yael Laitman, Anya Kushnir, Shani Paluch–Shimon, Raanan Berger, Jamal Zidan, Eitan Friedman, Hans Ehrencrona, Marie Stenmark‐Askmalm, Zakaria Einbeigi, Niklas Loman, Katja Harbst, Johanna Rantala, Beatrice Melin, Dezheng Huo, Olufunmilayo I. Olopade, Joyce Seldon, Patricia A. Ganz, Robert L. Nussbaum, Salina Chan, Kunle Odunsi, Simon A. Gayther, Susan M. Domchek, Banu Arun, Karen H. Lu, Gillian Mitchell, Beth Y. Karlan, Christine Walsh, Jenny Lester, Andrew K. Godwin, Harsh B. Pathak, Eric A. Ross, Mary B. Daly, Alice S. Whittemore, Esther M. John, Alexander Miron, Mary Beth Terry, Wendy K. Chung, David E. Goldgar, Saundra S. Buys, Ramūnas Janavičius, Laima Tihomirova, Nadine Tung, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Linda Steele, Susan L. Neuhausen, Yuan Chun Ding, Bent Ejlertsen, Anne‐Marie Gerdes, Thomas van Overeem Hansen, Teresa Ramón y Cajal, Ana Osório, Javier Benı́tez, Javier Godino, María‐Isabel Tejada, M. Durán, Jeffrey N. Weitzel, Kristie Bobolis, Sharon Sand, Annette Campbell Fontaine, Antonella Savarese, Barbara Pasini, Bernard Peissel, Bernardo Bonanni, Daniela Zaffaroni, Francesca Vignolo-Lutati, Giulietta Scuvera, Giuseppe Giannini, Loris Bernard, Maurizio Genuardi, Paolo Radice, Riccardo Dolcetti, Siranoush Manoukian, Valeria Pensotti, Viviana Gismondi, Drakoulis Yannoukakos, Florentia Fostira, Judy E. Garber, Diana Torres, Muhammad Usman Rashid, Ute Hamann, Susan Peock, Debra Frost, Radka Platte, D. Gareth Evans, Rosalind A. Eeles, Rosemarie Davidson, Diana Eccles, Trevor Cole
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
Reshma Rangwala, Robert D. Leone, Yunyoung C Chang, Leslie A. Fecher, Lynn M. Schuchter, Amy Kramer, Kay-See Tan, Daniel F. Heitjan, Glenda Rodgers, Maryann Gallagher, Shengfu Piao, Andrea B. Troxel, Tracey L. Evans, Angela DeMichele, Katherine L. Nathanson, Peter J. O’Dwyer, Jonathon Kaiser, Laura Pontiggia, Lisa E. Davis, Ravi K. Amaravadi